Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

The purpose of this study is to determine feasibility and acceptability of a six-week at-home light therapy protocol in childhood cancer survivors, to identify facilitators and barriers to implementing this intervention, and to measure signs and symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN) at baseline and following completion of the at-home light therapy protocol.

NCT Number	NCT07019259
Lead Sponsor	Yale University Collaborators: Rally Foundation for Childhood Cancer Research
Conditions	Cancer, Childhood Cancer, Chemotherapy-induced Peripheral Neuropathy
Enrollment	20 participants
Start Date	2025-06-30
Primary Completion	2027-04 (estimated)
Study Completion	2027-04 (estimated)
Updated on ClinicalTrials.gov	2026-06-12